Ensign Peak Advisors’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Other funds holding AGIO
Ensign Peak Advisors's AGIO Position: Q3 2026 in Review
Ensign Peak Advisors reduced its Agios Pharmaceuticals (AGIO) stake by 98% in Q3 2026, selling an estimated $10.2M and leaving 4,870 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #1448.
Ensign Peak Advisors first reported a position in AGIO in Q4 2021 and has held it in 20 quarters since. The position peaked at $11M in Q2 2026. 180 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.
- Ensign Peak Advisors held 4,870 shares of Agios Pharmaceuticals worth $162K as of Q3 2026.
- Ensign Peak Advisors sold 292,760 Agios Pharmaceuticals shares in Q3 2026, an estimated $10.2M.
- Agios Pharmaceuticals made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q3 2026, its #1448 holding.
- Ensign Peak Advisors first reported a position in Agios Pharmaceuticals in Q4 2021 and has held it in 20 quarters since.
- Ensign Peak Advisors's Agios Pharmaceuticals position peaked at $11M in Q2 2026.
- 180 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.
Based on Ensign Peak Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.